Posts Tagged ‘Biotechnology’

XTL Biopharmaceuticals Returns to NASDAQ

  XTL Biopharmaceuticals Ltd. (the « Company ») (tase:XTL), XTLBY -1.05% announced today that NASDAQ approved the Company’s listing application and its ADRs will be listed for trading on NASDAQ under the ticker symbol « XTLB ».

Massachusetts and Israel Continue to Support R&D Collaborations in the Life Sciences

TEL AVIV, Israel – June 11, 2013 – MATIMOP, the Israeli implementation agency, on behalf of the Office of the Chief Scientist (OCS) in the Ministry of Economy, and the Massachusetts Life Sciences Center (MLSC) today announced at the Biomed-IL conference in Tel Aviv the second round of grants awarded under the Massachusetts-Israel Innovation Partnership […]

Billionaire Frost’s Opko to Buy Prolor in $480 Million Deal

Opko Health Inc. (OPK) agreed to buy Israeli drugmakerProlor Biotech Inc. (PBTH) for about $480 million to combine two companies that count U.S. pharmaceutical billionaire Phillip Frost as their largest shareholder. Opko, based in Miami, will pay about $7 a share in stock for each Prolor share, according to a statement from the companies today. The price is […]

Syneron Launches its Proprietary Sublative Technology for Acne Scars

YOKNEAM, Israel, April 4, 2013 /PRNewswire/ — Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that it will begin the market launch of its proprietary Sublative technology for the removal or modification of the appearance of acne scars. The acne scar treatment is available on all of the Syneron Sublative compatible systems, which includes elōs […]

RegeneCure Bone Fracture Implant 40% Faster Healing

RegeneCure announced the successful results of a clinical study in pets using the company’s regenerative membrane implant technology for the treatment of bone fractures. The study showed that the healing time was about 40 percent quicker than normally observed using current Standard of Care therapies. The product was also demonstrated to be safe in all […]

Flies model a potential sweet treatment for Parkinson’s disease

Researchers from Tel Aviv University describe experiments that could lead to a new approach for treating Parkinson’s disease (PD) using a common sweetener, mannitol. This research is presented today at the Genetics Society of America’s 54th Annual Drosophila Research Conference in Washington D.C., April 3-7, 2013.

BioLineRx Announces Results from Interim Analysis of Phase II/III CLARITY Trial of BL-1020 for Schizophrenia

BioLineRx (BLRX) (BLRX.TA), a biopharmaceutical development company [based out of Jerusalem], today announced that results from a pre-planned interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia, indicate that the trial would not meet the pre-specified primary efficacy endpoint. After conferring […]

Dario Turns Diabetics’ Smartphones Into Trendy Glucometers

Being diabetic is not only an illness, it can also be a real social impediment, as diabetics have to keep their insulin levels in check throughout the day and test themselves with cumbersome devices. Dario is a glucometer attachment and application for smartphones. This device has all the integrated facilities to measure the glucose in the blood. […]